SG Americas Securities
DNA icon

SG Americas Securities’s Ginkgo Bioworks DNA Stock Holding History

SG Americas Securities’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-8,375
Closed -$17K – 3458
2022
Q1 		$17K Buy
8,375
+7,875
+1,575% +$1.53M ﹤0.01% 2890
2021
Q4 		$1K Buy
+500
New +$238K ﹤0.01% 3325

Other funds holding DNA

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SG Americas Securities's DNA Position: Q3 2025 in Review

SG Americas Securities sold out of Ginkgo Bioworks (DNA) in Q3 2025, closing a stake of 12,369 shares — an estimated $139K sold.

SG Americas Securities first reported a position in DNA in Q3 2021 and held it in 14 quarters. The position peaked at $1.51M in Q3 2021. 173 funds tracked by Wall St. Rank hold DNA as of Q3 2025.

  • SG Americas Securities reported no remaining Ginkgo Bioworks position as of Q3 2025 after selling out during the quarter.
  • SG Americas Securities sold 12,369 Ginkgo Bioworks shares in Q3 2025, an estimated $139K.
  • SG Americas Securities first reported a position in Ginkgo Bioworks in Q3 2021 and held it in 14 quarters.
  • SG Americas Securities's Ginkgo Bioworks position peaked at $1.51M in Q3 2021.
  • 173 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q3 2025.

Based on SG Americas Securities's 13F filing for Q3 2025, filed 23 Oct 2025.